MELBOURNE, Australia, Nov. 26, 2025 /PRNewswire/ — Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) (“Neurizon” or “the Company”), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce […]
New addition strengthens SK Biopharmaceuticals’ radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partnerships and value chain integration SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ — SK Biopharmaceuticals, CO., Ltd., a biotech company specializing […]
Chinese brand debuts MagiCCrystal CaHA Filler and presents patented ACD‑MT and PCD‑ETT technologies with leading clinicians Dr. Wang Wenting and Dr. Chen Lorraine RIYADH, Saudi Arabia, Nov. 27, 2025 /PRNewswire/ — Aphranel, a China-based original aesthetic […]
MELBOURNE, Australia, Nov. 26, 2025 /PRNewswire/ — Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) (“Neurizon” or “the Company”), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, is pleased to announce […]
HOUSTON, Nov. 26, 2025 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), is aware of a short seller report issued on November 25, 2025 by Capybara Research. Based on publicly available […]
